STOCK TITAN

Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Integra LifeSciences reschedules the release of its first quarter 2024 financial results to May 6, 2024, and will host a conference call. Investors can join the call via webcast on the Company's website.
Integra LifeSciences ha posticipato la pubblicazione dei risultati finanziari del primo trimestre 2024 al 6 maggio 2024 e terrà una conferenza telefonica. Gli investitori possono partecipare alla chiamata tramite webcast sul sito web della società.
Integra LifeSciences ha reprogramado la publicación de sus resultados financieros del primer trimestre de 2024 para el 6 de mayo de 2024, y realizará una llamada de conferencia. Los inversores pueden unirse a la llamada a través de una transmisión web en el sitio web de la compañía.
Integra LifeSciences는 2024년 1분기 재무 결과 발표를 2024년 5월 6일로 연기하고 컨퍼런스 콜을 개최할 예정입니다. 투자자들은 회사 웹사이트에서 웹캐스트를 통해 전화 회의에 참여할 수 있습니다.
Integra LifeSciences a reporté la publication de ses résultats financiers pour le premier trimestre 2024 au 6 mai 2024, et organisera une conférence téléphonique. Les investisseurs peuvent rejoindre l'appel via webcast sur le site web de la société.
Integra LifeSciences hat die Veröffentlichung seiner Finanzergebnisse für das erste Quartal 2024 auf den 6. Mai 2024 verschoben und wird eine Telefonkonferenz abhalten. Investoren können über einen Webcast auf der Unternehmenswebsite an dem Anruf teilnehmen.
Positive
  • None.
Negative
  • None.

PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. EDT.

A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

About Integra LifeSciences

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands that include Acclarent®, AmnioExcel®, Aurora®, Bactiseal®, BioD™, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, DuraSorb®, Gentrix®, ICP Express®, Integra®, Licox®, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, NeuraGen®, NeuraWrap™, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com   

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com 


Integra LifeSciences Holdings Corporation


FAQ

When has Integra LifeSciences rescheduled the release of its first quarter 2024 financial results?

Integra LifeSciences has rescheduled the release of its first quarter 2024 financial results to May 6, 2024.

What time will Integra LifeSciences host the conference call?

Integra LifeSciences will host the conference call at 8:30 a.m. EDT.

Where can investors access the live webcast of Integra LifeSciences' conference call?

Investors can access the live webcast of Integra LifeSciences' conference call on the Investors section of the Company's website at investor.integralife.com.

How can participants register for the conference call?

Participants can register for the conference call by visiting the Company's website to receive dial-in details and an individual pin.

Will a webcast replay of the conference call be available?

Yes, a webcast replay of the conference call will be available on the Investors section of the Company's website following the call.

Integra LifeSciences Holdings

NASDAQ:IART

IART Rankings

IART Latest News

IART Stock Data

2.27B
67.22M
13.81%
88.65%
2.66%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
United States of America
PRINCETON

About IART

integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li